Form 4: Axon Enterprise Director Julie A. Cullivan Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Director Julie A. Cullivan sold 993 shares of Axon Enterprise, Inc. at a price of $281.72 per share on May 31, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On May 31, 2024, Julie A. Cullivan, a director of Axon Enterprise, Inc., sold 993 shares of common stock.
- The sale was executed at a price of $281.72 per share.
- The transaction was conducted under a pre-existing Rule 10b5-1 trading plan adopted on June 10, 2023.
- Following the transaction, Cullivan directly owns 4,553 shares of Axon Enterprise, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a stock sale by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales by insiders are a normal part of corporate activity. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific inside information.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 06/10/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 05/31/2024 | Date of the transaction (sale of shares) |
| 06/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.